Atlas Venture Life Science Advisors, LLC Spero Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $799 Million
- Q1 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 607,613 shares of SPRO stock, worth $789,896. This represents 0.13% of its overall portfolio holdings.
Number of Shares
607,613
Previous 1,013,438
40.04%
Holding current value
$789,896
Previous $1.49 Million
29.82%
% of portfolio
0.13%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding SPRO
# of Institutions
53Shares Held
15.4MCall Options Held
19.6KPut Options Held
0-
Anson Funds Management LP Dallas, TX3.75MShares$4.88 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$2.15 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.76 Million14.54% of portfolio
-
Adar1 Capital Management, LLC Austin, TX927KShares$1.21 Million0.36% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$1.16 Million0.07% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $45.6M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...